The DOI matches its Crossref record; 51 of the 52 references it cites were found in a registry or an index.
Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer’s disease
Open accessAbstract
Genome-wide association studies (GWAS) have identified several risk variants for late-onset Alzheimer's disease (LOAD). These common variants have replicable but small effects on LOAD risk and generally do not have obvious functional effects. Low-frequency coding variants, not detected by GWAS, are predicted to include functional variants with larger effects on risk. To identify low-frequency coding variants with large effects on LOAD risk, we carried out whole-exome sequencing (WES) in 14 large LOAD families and follow-up analyses of the candidate variants in several large LOAD case-control data sets. A rare variant in PLD3 (phospholipase D3; Val232Met) segregated with disease status in two independent families and doubled risk for Alzheimer's disease in seven independent case-control series with a total of more than 11,000 cases and controls of European descent. Gene-based burden analyses in 4,387 cases and controls of European descent and 302 African American cases and controls, with complete sequence data for PLD3, reveal that several variants in this gene increase risk for Alzheimer's disease in both populations. PLD3 is highly expressed in brain regions that are vulnerable to Alzheimer's disease pathology, including hippocampus and cortex, and is expressed at significantly lower levels in neurons from Alzheimer's disease brains compared to control brains. Overexpression of PLD3 leads to a significant decrease in intracellular amyloid-β precursor protein (APP) and extracellular Aβ42 and Aβ40 (the 42- and 40-residue isoforms of the amyloid-β peptide), and knockdown of PLD3 leads to a significant increase in extracellular Aβ42 and Aβ40. Together, our genetic and functional data indicate that carriers of PLD3 coding variants have a twofold increased risk for LOAD and that PLD3 influences APP processing. This study provides an example of how densely affected families may help to identify rare variants with large effects on risk for disease or other complex traits.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Most of the genes associated with the ~40 loci identified by genome-wide association (GWA) analysis or by rare variant sequencing studies are expressed in glial cells (e.g., APOE, TREM2, BIN1, CD33, INPP5D, CTSB, CTSD, and PICALM).”
From The Major Risk Factors for Alzheimer’s Disease: Age, Sex, and Genes Modulate the Microglia Response to Aβ Plaques (2019) · cites this paper as Cruchaga et al., 2014
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“gene enrichment analysis indicates that ARMs, but not IRMs, are enriched for known AD risk genes such as Apoe, Trem2, Tyrobp (DAP12), Ctsb, Ctsd, H2-Eb1, and Pld3”
From The Major Risk Factors for Alzheimer’s Disease: Age, Sex, and Genes Modulate the Microglia Response to Aβ Plaques (2019) · cites this paper as Cruchaga et al., 2014
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“whereas the PLD3 variant, V232M, was identified using a family-based study design [13].”
From Linkage, whole genome sequence, and biological data implicate variants in RAB10 in Alzheimer’s disease resilience (2017) · cites this paper as [13]
The cited source says what the claim attributes to it.
In the citing paper
“Recently, several possibly functional, rare variants with large protective [9, 10] and risk effects [11–13] have been identified for AD in APP, APOE, PLD3, and TREM2 using novel study designs.”
From Linkage, whole genome sequence, and biological data implicate variants in RAB10 in Alzheimer’s disease resilience (2017) · cites this paper as [13]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“We also found that LECs isolated from the meninges of 6-month-old 5xFAD mice showed significant changes in the expression of genes involved in processes such as exocytosis, phospholipase D signaling, and response to low-density lipoprotein (Extended Data Fig. 1f–k), suggesting that meningeal Aβ deposition might affect meningeal LECs early on through deleterious processes previously implicated in”
From Meningeal lymphatics affect microglia responses and anti-Aβ immunotherapy (2021) · cites this paper as [14]
Experimental — accuracy not yet measured
In the citing paper
“For example, rare variants in SORL1 and ABCA7 have been identified in family-based studies of LOAD [147–150], each of which have been associated with alterations in APP processing.”
From Genetic architecture of Alzheimer's disease (2020) · cites this paper as [149]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
WGCNA: an R package for weighted correlation network analysis
Langfelder, P., & Horvath, S. (2008) · BMC Bioinformatics · doi:10.1186/1471-2105-9-559 · Cited by 27,252
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn923 · Cited by 14,108
The Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
Self-citationA General Framework for Weighted Gene Co-Expression Network Analysis
Zhang, B., & Horvath, S. (2005) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1128 · Cited by 5,684
Cleveland, D. W., Fischer, S. G., Kirschner, M. W., & Laemmli, U. K. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)75212-0 · Cited by 5,556
Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium
McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069
Self-citationMeta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease
(EADI), E. A. D. I., Lambert, J.-C., (GERAD), G. A. E. R. I. A. D., Alzheimer's Disease Genetic Consortium (ADGC), (CHARGE), C. F. H. A. A. R. I. G. E., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2802 · Cited by 4,336
Self-citationTREM2 Variants in Alzheimer's Disease
Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S. K., Younkin, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211851 · Cited by 3,020
Self-citation
Research works printed but not linked: 1
- Benitez, B. A. & Cruchaga, C. TREM2 and neurodegenerative disease. N. Engl. J. Med. 369, 1567–1568 (2013)
Cited by
Sorted by citations
Items 201–300 of 463
Ohashi, R., & Shiina, N. (2020) · Biomolecules · doi:10.3390/biom10020167 · Cited by 33
Association of rare variants in neurodegenerative genes with familial Alzheimer’s disease
Zhang, W., Jiao, B., Xiao, T., Liu, X., Liao, X., Xiao, X., Guo, L., Yuan, Z., Yan, X., Tang, B., et al. (2020) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51197 · Cited by 28
Genomics in Neurological Disorders
Han, G., Sun, J., Wang, J., Bai, Z., Song, F., & Lei, H. (2014) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2014.07.002 · Cited by 29
Family studies to find rare high risk variants in migraine
Hansen, R. D., Christensen, A. F., & Olesen, J. (2017) · The Journal of Headache and Pain · doi:10.1186/s10194-017-0729-y · Cited by 27
Genome-wide significant risk factors on chromosome 19 and the APOE locus
Moreno–Grau, S., Initiative, A. D. N., Hernández, I., Heilmann‐Heimbach, S., Ruiz, S., Rosende‐Roca, M., Mauleón, A., Vargas, L., Rodríguez‐Gómez, O., Alegret, M., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.25083 · Cited by 26
Cai, Y., Kanyo, J. E., Wilson, R. S., Bathla, S., Cardozo, P. L., Тонг, Л., Qin, S., Fuentes, L. A., Pinheiro‐de‐Sousa, I., Huynh, T., et al. (2025) · Nature Aging · doi:10.1038/s43587-025-00823-3 · Cited by 27
Self-citationGenomic aspects of sporadic neurodegenerative diseases
Mitsui, J., & Tsuji, S. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.07.098 · Cited by 27
A Brief Synopsis on the Genetics of Alzheimer’s Disease
Kamboh, M. I. (2018) · Current Genetic Medicine Reports · doi:10.1007/s40142-018-0155-8 · Cited by 26
Self-citationThe transcriptional landscape of Alzheimer’s disease and its association with Wnt signaling pathway
Martínez, M., & Inestrosa, N. C. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.06.029 · Cited by 26
Goodman, L. D., & Bellen, H. J. (2021) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2021.07.012 · Cited by 29
Determination of miR-373 and miR-204 levels in neuronal exosomes in Alzheimer?s disease
Taşdelen, E., Ozel-Kizil, E. T., Aydemir, S. T., Yalap, Ö. E., Bingol, A. P., & Kutlay, N. Y. (2022) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.55730/1300-0144.5484 · Cited by 26
ADNI, Nho, K. T., Horgusluoglu, E., Kim, S., Risacher, S. L., Kim, D., Foroud, T., Aisen, P. S. S., Petersen, R. C., Jack, C. R., et al. (2016) · BMC Medical Genomics · doi:10.1186/s12920-016-0190-9 · Cited by 26
Cukier, H. N., Kunkle, B. K., Hamilton, K. L., Rolati, S., Kohli, M. A., Whitehead, P. L., Jaworski, J. M., Vance, J. M., Cuccaro, M. L., Carney, R. M., et al. (2017) · Journal of Alzheimer’s Disease & Parkinsonism · doi:10.4172/2161-0460.1000355 · Cited by 27
Mukadam, A. S., Breusegem, S. Y., & Seaman, M. N. J. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2752-9 · Cited by 26
Gelfman, S., Dugger, S. A., Moreno, C. A. M., Ren, Z., Wolock, C. J., Shneider, N. A., Phatnani, H. P., Cirulli, E. T., Lasseigne, B. N., Harris, T., et al. (2019) · Genome Research · doi:10.1101/gr.243592.118 · Cited by 29
A Mutation in DAOA Modifies the Age of Onset in PSEN1 E280A Alzheimer’s Disease
Vélez, J. I., Rivera, D., Mastronardi, C. A., Patel, H. R., Tobón, C., Villegas, A., Cai, Y., Easteal, S., Lopera, F., & Arcos-Burgos, M. (2016) · Neural Plasticity · doi:10.1155/2016/9760314 · Cited by 25
Self-citationLopes, F. L., Hou, L., Boldt, A. B. W., Kassem, L., Alves, V. D. M., Nardi, A. E., & McMahon, F. J. (2016) · Human Biology · doi:10.13110/humanbiology.88.2.0109 · Cited by 25
Barral, S., Cheng, R., Reitz, C., Vardarajan, B., Lee, J. H., Kunkle, B. W., Beecham, G., Cantwell, L. S., Pericak-Vance, M., Farrer, L., et al. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2015.07.487 · Cited by 26
Self-citationCacace, R., den Bossche, T. V., Engelborghs, S., Geerts, N., Laureys, A., Dillen, L., Graff, C., Thonberg, H., Chiang, H., Pástor, P., et al. (2015) · Human Mutation · doi:10.1002/humu.22908 · Cited by 25
New molecular approaches to Alzheimer's disease
Resta, C. D., & Ferrari, M. (2019) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2019.04.010 · Cited by 26
ATRAID regulates the action of nitrogen-containing bisphosphonates on bone
Surface, L. E., Burrow, D. T., Li, J., Park, J., Kumar, S., Lyu, C., Song, N., Yu, Z., Rajagopal, A., Bae, Y., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aav9166 · Cited by 27
Association of CD2AP neuronal deposits with Braak neurofibrillary stage in Alzheimer’s disease
Camacho, J., Rábano, A., Marazuela, P., Bonaterra‐Pastra, A., Serna, G., Moliné, T., y Cajal, S. R., Martínez-Sáez, E. A., & Hernández‐Guillamón, M. (2021) · Brain Pathology · doi:10.1111/bpa.13016 · Cited by 25
Ryu, S., Han, J., Norden‐Krichmar, T. M., Schork, N. J., & Suh, Y. (2018) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2018.03.007 · Cited by 25
Schreiber, M. A., Bird, T. D., & Tsuang, D. W. (2014) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-014-0026-x · Cited by 25
Zhang, W., Jiao, B., Zhou, M., Zhou, T., & Shen, L. H. (2016) · Stem Cells International · doi:10.1155/2016/7828049 · Cited by 26
Tau Interacting Proteins: Gaining Insight into the Roles of Tau in Health and Disease
Stancu, I., Ferraiolo, M., Terwel, D., & Dewachter, I. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9358-8_13 · Cited by 23
Kim, Y. W., Al‐Ramahi, I., Koire, A. M., Wilson, S. J., Konecki, D. M., Mota, S., Soleimani, S., Botas, J., & Lichtarge, O. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12240 · Cited by 22
SORL1 variants across Alzheimer’s disease European American cohorts
NIA-LOAD family study group, N., Fernández, M. V., Black, K., Carrell, D., Saef, B. A., Budde, J., Deming, Y. K., Howells, B., Del‐Aguila, J. L., Ma, S., et al. (2016) · European Journal of Human Genetics · doi:10.1038/ejhg.2016.122 · Cited by 20
Self-citationAnalysis of population-specific pharmacogenomic variants using next-generation sequencing data
Ahn, E., & Park, T. (2017) · Scientific Reports · doi:10.1038/s41598-017-08468-y · Cited by 24
One for all and all for One: Improving replication of genetic studies through network diffusion
Lancour, D., Naj, A. C., Mayeux, R. P., Haines, J. L., Pericak‐Vance, M. A., Schellenberg, G. D., Crovella, M. E., Farrer, L. A., & Kasif, S. (2018) · PLoS Genetics · doi:10.1371/journal.pgen.1007306 · Cited by 24
Phospholipase D1 Ablation Disrupts Mouse Longitudinal Hippocampal Axis Organization and Functioning
Marinha, L. S., Castanho, I., Silva, R. R., Bravo, F. V., Miranda, A. M., Meira, T., Morais‐Ribeiro, R., Marques, F., Xu, Y., du Jour, K. P., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2020.02.102 · Cited by 23
Yang, J., Wang, Z., Liu, S., Wang, W., Zhang, H., & Gui, C. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00747 · Cited by 24
Clinical genetic strategies for early onset neurodegenerative diseases
Giau, V. V., Bagyinszky, E., An, S. S. A., & Kim, S. (2018) · Molecular & Cellular Toxicology · doi:10.1007/s13273-018-0015-3 · Cited by 23
Egawa, J., Hoya, S., Watanabe, Y., Nunokawa, A., Shibuya, M., Ikeda, M., Inoue, E., Okuda, S., Kondo, K., Saito, T., et al. (2016) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32444 · Cited by 21
Smith, A. R., Mill, J. S., Smith, R. G., & Lunnon, K. (2016) · Neuroepigenetics · doi:10.1016/j.nepig.2016.05.001 · Cited by 21
The Increasing Importance of Gene-Based Analyses
Cirulli, E. T. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1005852 · Cited by 22
Interaction between variants in CLU and MS4A4E modulates Alzheimer's disease risk
Ebbert, M., Boehme, K. L., Wadsworth, M. E., Staley, L. A., Initiative, A. D. N., Mukherjee, S., Crane, P. K., Ridge, P. G., & Kauwe, J. S. K. (2015) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2015.08.163 · Cited by 23
Self-citationRole of phospholipases in adrenal steroidogenesis
Bollag, W. B. (2016) · Journal of Endocrinology · doi:10.1530/joe-16-0007 · Cited by 21
Tang, W., Nalehua, M. R., Basu, S., Heckbert, S. R., Cushman, M., Pankow, J. S., Folsom, A. R., & Pankratz, N. (2019) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14676 · Cited by 21
Mechanism of enzymatic reaction and protein–protein interactions of PLD from a 3D structural model
Mahankali, M., Alter, G. M., & Gómez-Cambronero, J. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.09.008 · Cited by 21
Cappel, C. C., Gonzalez, A. C., & Daμμe, M. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.015867 · Cited by 19
Progress in methods for rare variant association
Santorico, S. A., & Hendricks, A. E. (2016) · BMC Genetics · doi:10.1186/s12863-015-0316-7 · Cited by 22
Genetic profiles of familial late-onset Alzheimer's disease in China: The Shanghai FLOAD study
Xie, X., Zhao, Q., Huang, Q., Dammer, E. B., Chen, S., Ren, R., & Wang, G. (2021) · Genes & Diseases · doi:10.1016/j.gendis.2021.05.001 · Cited by 20
Jiao, B., Xiao, X., Yuan, Z., Guo, L., Liao, X., Zhou, Y., Zhou, L., Wang, X., Liu, X., Liu, H., et al. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-021-01258-1 · Cited by 20
Self-citationExploring the potential role of rab5 protein in endo-lysosomal impairment in Alzheimer’s disease
Behl, T., Kaur, D., Sehgal, A., Singh, S., Makeen, H. A., Albratty, M., Abdellatif, A. A. H., Dachani, S. R., & BUNGAU, S. G. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112773 · Cited by 20
Exonucleases: Degrading DNA to Deal with Genome Damage, Cell Death, Inflammation and Cancer
Manils, J., Marruecos, L., & Soler, C. (2022) · Cells · doi:10.3390/cells11142157 · Cited by 20
Genome research in pre-dementia stages of Alzheimer's disease
Moreno–Grau, S., & Ruiz, A. (2016) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2016.12 · Cited by 20
Whole-Exome Sequencing of an Exceptional Longevity Cohort
Nygaard, H. B., Erson-Omay, Z., Wu, X., Kent, B. A., Bernales, C. Q., Evans, D. M., Farrer, M. J., Vilariño‐Güell, C., & Strittmatter, S. M. (2018) · The Journals of Gerontology Series A · doi:10.1093/gerona/gly098 · Cited by 20
Improving power for rare‐variant tests by integrating external controls
Lee, S., Kim, S., & Fuchsberger, C. (2017) · Genetic Epidemiology · doi:10.1002/gepi.22057 · Cited by 21
Mutations modifying sporadic Alzheimer’s disease age of onset
Vélez, J. I., Lopera, F., Patel, H. R., Johar, A. S., Cai, Y., Rivera, D., Tobón, C., Villegas, A., Sepulveda‐Falla, D., Lehmann, S. G., et al. (2016) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32493 · Cited by 19
Self-citationCommon Variants in PLD3 and Correlation to Amyloid-Related Phenotypes in Alzheimer’s Disease
Wang, C., Alzheimer’s1, D. N. I., Tan, L., Wang, H.-F., Yu, W.-J., Liu, Y., Jiang, T., Tan, M., Hao, X., Zhang, D., et al. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150110 · Cited by 19
Wood, P. L., Cebak, J. E., & Woltjer, R. L. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.11.009 · Cited by 20
Saad, M., Brkanac, Z., & Wijsman, E. M. (2015) · Genes Brain & Behavior · doi:10.1111/gbb.12250 · Cited by 19
Self-citationEngelman, C. D., Darst, B. F., Bilgel, M., Vasiljevic, E., Koscik, R. L., Jedynak, B., & Johnson, S. C. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.12.025 · Cited by 19
Roske, Y., Cappel, C. C., Cremer, N., Hoffmann, P., Koudelka, T., Tholey, A., Heinemann, U., Daumke, O., & Daμμe, M. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad1114 · Cited by 17
Cortical lipid metabolic pathway alteration of early Alzheimer’s disease and candidate drugs screen
Wang, L., Qu, F., Yu, X., Yang, S., Zhao, B., Chen, Y., Li, P., Zhang, Z., Zhang, J., Han, X., et al. (2024) · European journal of medical research · doi:10.1186/s40001-024-01730-w · Cited by 20
Stein-O’Brien, G., Palaganas, R. G., Meyer, E. M., Redding‐Ochoa, J., Pletniková, O., Guo, H., Bell, W. R., Troncoso, J. C., Huganir, R. L., & Morris, M. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115422 · Cited by 18
Comparison of multi-sample variant calling methods for whole genome sequencing
Nho, K. T., West, J. D., Li, H., Henschel, R., Tavares, M. C., Sanjay, A. B., Weiner, M. W., Green, R. C., Toga, A. W., & Saykin, A. J. (2014) · IEEE International Conference on Systems Biology · doi:10.1109/isb.2014.6990432 · Cited by 18
Alzheimer's disease research in the context of the national plan to address Alzheimer's disease
Snyder, H. M., Hendrix, J. A., Bain, L. J., & Carrillo, M. C. (2015) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2015.06.005 · Cited by 18
Rare Variants in PLD3 Increase Risk for Alzheimer’s Disease in Han Chinese
Tan, M., Zhu, J., Cao, X., Yu, J., & Tan, L. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180205 · Cited by 17
Defective Lysosomal Lipid Catabolism as a Common Pathogenic Mechanism for Dementia
Lee, J. Y., Marian, O. C., & Don, A. S. (2021) · NeuroMolecular Medicine · doi:10.1007/s12017-021-08644-4 · Cited by 18
Pan, G., King, A. E., Wu, F., Simpson, S., Woodhouse, A., Phipps, A., & Vickers, J. C. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101402 · Cited by 19
Next Generation Sequencing in Alzheimer’s Disease
Bertram, L. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2627-5_17 · Cited by 18
Song, F., Han, G., Bai, Z., Peng, X., Wang, J., & Lei, H. (2015) · International review of neurobiology · doi:10.1016/bs.irn.2015.05.001 · Cited by 16
Analysis of high‐risk pedigrees identifies 11 candidate variants for Alzheimer's disease
Teerlink, C. C., Miller, J. B., Vance, E. L., Staley, L. A., Stevens, J., Tavana, J. P., Cloward, M. E., Page, M. L., Dayton, L., Cannon‐Albright, L., et al. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12397 · Cited by 16
Self-citationExcess of rare coding variants in PLD3 in late- but not early-onset Alzheimer’s disease
Schulte, E. C., Kurz, A., Alexopoulos, P., Hampel, H. J., Peters, A., Gieger, C., Rujescu, D., Diehl‐Schmid, J., & Winkelmann, J. (2015) · Human Genome Variation · doi:10.1038/hgv.2014.28 · Cited by 17
Genetic variations in olfactory receptor gene OR2AG2 in a large multigenerational family with asthma
Chakraborty, S., Dakle, P., Sinha, A., Vishweswaraiah, S., Nagori, A., Salimath, S., Prakash, Y. S., Lodha, R., Kabra, S. K., Ghosh, B., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-54718-6 · Cited by 16
A novel approach for multi-SNP GWAS and its application in Alzheimer’s disease
Initiative, T. A. D. N., Bodily, P., Fujimoto, M., Page, J. T., Clement, M., Ebbert, M., & Ridge, P. G. (2016) · BMC Bioinformatics · doi:10.1186/s12859-016-1093-7 · Cited by 17
Self-citationPiccoli, E., Rossi, G., Rossi, T., Pelliccioni, G., D’Amato, I., Tagliavini, F., & Fede, G. D. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.01.134 · Cited by 15
Genetic Study of Alzheimer’s Disease in Saudi Population
Bitar, F. E., Qadi, N., Rajeh, S. A., Majrashi, A., Abdulaziz, S., Majrashi, N., Inizi, M. A., Taher, A., & Tassan, N. A. A. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-180415 · Cited by 14
Hoshino, F., & Sakane, F. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2020.158768 · Cited by 15
Lysosomal gene Hexb displays haploinsufficiency in a knock-in mouse model of Alzheimer’s disease
Whyte, L. S., Fourrier, C., Hassiotis, S., Lau, A. A., Trim, P. J., Hein, L. K., Hattersley, K. J., Bensalem, J., Hopwood, J. J., Hemsley, K. M., et al. (2022) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2022.01.004 · Cited by 14
Gaeta, A. L., Nourse, J. B., Willicott, K., McKay, L. E., Keogh, C. M., Peter, K., Russell, S. N., Hamamichi, S., Berkowitz, L. A., Caldwell, K. A., et al. (2022) · PLoS Genetics · doi:10.1371/journal.pgen.1010115 · Cited by 15
Kim, D., Basile, A. O., Bang, L., Horgusluoglu, E., Lee, S., Ritchie, M. D., Saykin, A. J., & Nho, K. T. (2017) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-017-0454-0 · Cited by 16
Imm, J. L., Kerrigan, T. L., Jeffries, A. R., & Lunnon, K. (2017) · Epigenomics · doi:10.2217/epi-2017-0076 · Cited by 14
Genetic Complexity of Early-Onset Alzheimer’s Disease
Ghani, M., Reitz, C., George‐Hyslop, P. S., & Rogaeva, E. A. (2018) · Springer eBooks · doi:10.1007/978-3-319-72938-1_3 · Cited by 15
Self-citationAn inclusive study of recent advancements in Alzheimer's disease: A comprehensive review
Singh, S., Mahajan, M., Kumar, D., Singh, K., Chowdhary, M., & Amit (2023) · Neuropeptides · doi:10.1016/j.npep.2023.102369 · Cited by 15
Chen, R., Wei, Q., Zhan, X., Zhong, X. Y., Sutcliffe, J. S., Cox, N. J., Cook, E. H., Li, C., Chen, W., & Li, B. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btu860 · Cited by 14
Initiative, A. D. N., Miller, J. E., Shivakumar, M., Lee, Y., Han, S., Horgousluoglu, E., Risacher, S. L., Saykin, A. J., Nho, K. T., & Kim, D. (2018) · BMC Medical Genomics · doi:10.1186/s12920-018-0390-6 · Cited by 14
V232M substitution restricts a distinct O-glycosylation of PLD3 and its neuroprotective function
Demirev, A. V., Song, H., Cho, M., Cho, K., Peak, J., Yoo, H. J., Kim, D., & Yoon, S. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.05.015 · Cited by 14
Becker, T., Cappel, C. C., Matteo, F. D., Sonsalla, G., Kamińska, E., Spada, F., Cappello, S., Daμμe, M., & Kielkowski, P. (2021) · iScience · doi:10.1016/j.isci.2021.103521 · Cited by 14
Mapping the genetic landscape of early-onset Alzheimer’s disease in a cohort of 36 families
Mol, M. O., van der Lee, S. J., Hulsman, M., Pijnenburg, Y. A. L., Scheltens, P., Bank, N. B., Seelaar, H., Swieten, J. C. V., Kaat, L. D., Holstege, H. H., et al. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-01018-3 · Cited by 14
Tosto, G., & Reitz, C. (2016) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2016.09.001 · Cited by 14
EIF2AK3 variants in Dutch patients with Alzheimer's disease
Wong, T. H., van der Lee, S. J., van Rooij, J., Meeter, L. H. H., Frick, P., Melhem, S., Seelaar, H., Ikram, M. A., Rozemüller, A. J. M., Holstege, H. H., et al. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.08.016 · Cited by 15
Towards a Unitary Hypothesis of Alzheimer’s Disease Pathogenesis
Área-Gómez, E., & Schon, E. A. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-231318 · Cited by 18
Defining the Genetic Architecture of Alzheimer's Disease: Where Next?
Sims, R., & Williams, J. H. (2015) · Neurodegenerative Diseases · doi:10.1159/000440841 · Cited by 13
Tan, M., Li, J., Ma, F., Zhang, X., Zhao, Q., & Cao, X. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00116 · Cited by 13
Ataxin-3 Links NOD2 and TLR2 Mediated Innate Immune Sensing and Metabolism in Myeloid Cells
Chapman, T., Corridoni, D., Shiraishi, S., Pandey, S., Aulicino, A., Wigfield, S., Costa, M. D. C., Thézénas, M., Paulson, H. L., Fischer, R., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01495 · Cited by 13
Cell type-selective disease-association of genes under high regulatory load
Galhardo, M., Berninger, P., Nguyen, T.-P., Sauter, T., & Sinkkonen, L. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv863 · Cited by 15
Chen, X., Pan, C., Xu, C., Sun, Y., Geng, Y., Kong, L., Xiao, X., Zhao, Z., Zhou, W., Huang, L., et al. (2019) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2019.4101 · Cited by 13
Cruchaga, C., Ali, M., Shen, Y., Do, A. N., Wang, L., Western, D., Liu, M., Beric, A., Budde, J., Gentsch, J., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-3631708/v1 · Cited by 14
Self-citationLysosomes as hubs of metabolic sensing and cellular homeostasis
Jain, A., & Zoncu, R. (2026) · Molecular Cell · doi:10.1016/j.molcel.2026.01.011 · Cited by 15
Structural and mechanistic insights into disease-associated endolysosomal exonucleases PLD3 and PLD4
Yuan, M., Peng, L., Huang, D., Gavin, A. L., Luan, F., Tran, J., Feng, Z., Zhu, X., Matteson, J., Wilson, I. A., et al. (2024) · Structure · doi:10.1016/j.str.2024.02.019 · Cited by 12
Basile, A. O., Wallace, J. R., Peissig, P. L., McCarty, C. A., Brilliant, M. H., & Ritchie, M. D. (2015) · Pacific Symposium on Biocomputing (PSB) · doi:10.1142/9789814749411_0024 · Cited by 12
A biologically informed method for detecting rare variant associations
Moore, C., Basile, A. O., Wallace, J. R., Frase, A., & Ritchie, M. D. (2016) · BioData Mining · doi:10.1186/s13040-016-0107-3 · Cited by 12
Reply: POLR3A variants in hereditary spastic paraplegia and ataxia
Minnerop, M., Kurzwelly, D., Rattay, T. W., Timmann, D., Hengel, H., Synofzik, M., Stendel, C., Horváth, R., Schüle, R., & Ramírez, A. (2017) · Brain · doi:10.1093/brain/awx291 · Cited by 12
Rare Variants and Transcriptomics in Alzheimer disease
Humphries, C., & Kohli, M. A. (2014) · Current Genetic Medicine Reports · doi:10.1007/s40142-014-0035-9 · Cited by 11
Kumar, S., Yadav, N., Pandey, S., & Thelma, B. K. (2018) · Journal of Genetics · doi:10.1007/s12041-018-0953-5 · Cited by 11
Li, H., Tsai, M., Huang, C., Wang, R., Chuang, L., Chen, N., Liu, C., Hsu, C., Cheng, W., & Lee, L. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8091361 · Cited by 11
Cognitive trajectories diverge by genetic risk in a preclinical longitudinal cohort
Vasiljevic, E., Koscik, R. L., Jonaitis, E. M., Betthauser, T. J., Johnson, S. C., & Engelman, C. D. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.12920 · Cited by 12
Metadata
- Authors
- Cruchaga, C., Karch, C. M., Jin, S. C., Benitez, B. A., Cai, Y., Guerreiro, R., Harari, O., Norton, J., Budde, J., Bertelsen, S., Jeng, A. T., Cooper, B., Skorupa, T., Carrell, D., Levitch, D., Hsu, S., Choi, J., Ryten, M., UK Brain Expression Consortium (UKBEC), Hardy, J., Ryten, M., Trabzuni, D., Weale, M. E., Ramasamy, A., Smith, C., Sassi, C., Bras, J., Gibbs, J. R., Hernandez, D. G., Lupton, M. K., Powell, J., Forabosco, P., Ridge, P. G., Corcoran, C. D., Tschanz, J. T., Norton, M. C., Munger, R. G., Schmutz, C., Leary, M., Demirci, F. Y., Bamne, M. N., Wang, X., Lopez, O. L., Ganguli, M., Medway, C., Turton, J., Lord, J., Braae, A., Barber, I., Brown, K., The Alzheimer’s Research UK (ARUK) Consortium, Passmore, P., Craig, D., Johnston, J., McGuinness, B., Todd, S., Heun, R., Kölsch, H., Kehoe, P. G., Hooper, N. M., Vardy, E. R. L. C., Mann, D. M., Pickering-Brown, S., Brown, K., Kalsheker, N., Lowe, J., Morgan, K., David Smith, A., Wilcock, G., Warden, D., Holmes, C., Pastor, P., Lorenzo-Betancor, O., Brkanac, Z., Scott, E., Topol, E., Morgan, K., Rogaeva, E., Singleton, A. B., Hardy, J., Kamboh, M. I., St George-Hyslop, P., Cairns, N., Morris, J. C., Kauwe, J. S. K., & Goate, A. M.
- Affiliations
- Washington University in St. Louis (US)
- National Institutes of Health (US)
- National Hospital for Neurology and Neurosurgery (GB)
- King's College London (GB)
- University of Edinburgh (GB)
- National Research Council (IT)
- Brigham Young University (US)
- Utah State University (US)
- University of Pittsburgh (US)
- University of Nottingham (GB)
- Queen's University Belfast (GB)
- Royal Derby Hospital (GB)
- University of Bonn (DE)
- University of Bristol (GB)
- University of Leeds (GB)
- Newcastle University (GB)
- University of Manchester (GB)
- University of Oxford (GB)
- University of Washington (US)
- Scripps Research Institute (US)
- University of Toronto (CA)
- Corresponding author
- Cruchaga, Carlos
- ORCID
- Cruchaga, Carlos
- Karch, Celeste M.
- Jin, Sheng Chih
- Guerreiro, Rita
- Harari, Oscar
- Budde, John
- Bertelsen, Sarah
- Skorupa, Tara
- Carrell, David
- Hsu, Simon
- Trabzuni, Daniah
- Weale, Michael E.
- Ramasamy, Adaikalavan
- Smith, Colin
- Sassi, Celeste
- Gibbs, J. Raphael
- Hernandez, Dena G.
- Lupton, Michelle K.
- Powell, John
- Forabosco, Paola
- Ridge, Perry G.
- Tschanz, JoAnn T.
- Norton, Maria C.
- Munger, Ronald G.
- Demirci, F. Yesim
- Wang, Xingbin
- Ganguli, Mary
- Turton, James
- Lord, Jenny
- Braae, Anne
- Passmore, Peter
- Craig, David
- McGuinness, Bernadette
- Todd, Stephen
- Heun, Reinhard
- Kehoe, Patrick G.
- Hooper, Nigel M.
- Vardy, Emma R.L.C.
- Mann, David M.
- Pickering-Brown, Stuart
- Kalsheker, Noor
- Lowe, James
- Wilcock, Gordon
- Holmes, Clive
- Scott, Erick
- Topol, Eric
- Rogaeva, Ekaterina
- Singleton, Andrew B.
- Kamboh, M. Ilyas
- Cairns, Nigel
- Morris, John C.
- Goate, Alison M.
- Venue
- Nature
- Published
- 2013-12-11
- Volume
- 505
- Issue
- 7484
- Pages
- 550-554
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4050701
- OpenAlex
- W2099248872
- Cited by
- 461
- References
- 52
- Citations by year
- 2026: 13 · 2025: 17 · 2024: 23 · 2023: 21 · 2022: 22 · 2021: 32 · 2020: 30 · 2019: 37 · 2018: 50 · 2017: 44 · 2016: 50 · 2015: 68 · 2014: 51
- FWCI
- 39.22
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Research Portal (Queen's University Belfast) (submittedVersion)
- Bristol Research (University of Bristol) (submittedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- U.S. Department of Health and Human Services
- Pfizer
- BrightFocus Foundation
- Wellcome Trust (100140, 089703, 081864, 089698)
- National Institute for Health and Care Research (ACF-2007-18-011, ACF-2012-17-017)
- National Institutes of Health (5p30ns069329-02)
- Genentech
- U.S. Public Health Service (NIH R01039700)
- Canadian Institutes of Health Research
- Medical Research Council (MR/K01417X/1, MC_G1000735, MR/L016400/1, MC_G1000734)
- National Institute on Aging (R01 AG 11380, R01AG039700, NIH P50AG05681, RF1AG044546, ZIAAG000950, R01AG042611, AG 07562, R01AG041718, AG-005133, P50AG005133, K01AG046374, AG041718, R01AG007562, R01AG030653, ZO1 AG000950-10, R01AG011380, R01AG035083, U24 AG21886, AG023652, R01AG021136, R01AG018712, R01AG041797, R01AG044546, R01 AG18712, ZO1AG000950-11, Z01AG000950, P50AG005681, P01 AG0 3991, P01AG003991, U24AG026395, R01 AG 21136, U24AG056270, P01AG026276, U24AG021886, AG 030653)
- National Institute on Drug Abuse (R25DA027995)
- National Institute of Neurological Disorders and Stroke (P30-NS069329)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- late-onset Alzheimer's disease, PLD3, rare coding variants, amyloid-beta processing, amyloid precursor protein, gene burden analysis, familial Alzheimer's disease, African Americans, European ancestry, therapeutic target, genetic risk variants
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Black or African American, Brain, Europe, Exodeoxyribonucleases, Female, Humans, Male, Peptide Fragments, Phospholipase D, Protein Processing, Post-Translational, Genetic Variation, Case-Control Studies, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Age of Onset, Genetic Predisposition to Disease, Exome, Proteolysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
